NCT05517304

Brief Summary

This study effects the effects of transcutaneous cervical vagal nerve stimulation (tcVNS) or a sham control on brain, physiology, and PTSD symptoms in Veterans with posttraumatic stress disorder (PTSD). Veterans undergo brain imaging and physiological measures in conjunction with traumatic scripts before and after three months of twice daily treatment with tcVNS or sham stimulation at home.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
18mo left

Started Oct 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Oct 2022Nov 2027

First Submitted

Initial submission to the registry

August 15, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 26, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 8, 2027

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2027

Last Updated

March 3, 2026

Status Verified

February 1, 2026

Enrollment Period

4.8 years

First QC Date

August 15, 2022

Last Update Submit

February 27, 2026

Conditions

Keywords

Stress Disorders, Post-TraumaticPTSDVagus Nerve

Outcome Measures

Primary Outcomes (2)

  • Change in PTSD symptoms

    Change in PTSD symptoms measured with the Clinician Administered PTSD Scale (CAPS) and PTSD Checklist (PCL) in tcVNS versus sham conditions

    Baseline to three months

  • Brain Activation

    Change in brain activation in insula measured with PET in response to trauma scripts with VNS compared to sham

    Baseline

Secondary Outcomes (2)

  • Sympathetic function

    Baseline

  • Interleukin-6

    Baseline

Study Arms (2)

tcVNS

EXPERIMENTAL

Stimulation twice daily with transcutaneous Vagal Nerve Stimulation (tcVNS)

Device: tcVNS

Sham

ACTIVE COMPARATOR

Stimulation with sham

Device: Sham

Interventions

tcVNSDEVICE

Active stimulation with transcutaneous Vagal Nerve Stimulation (tcVNS)

tcVNS
ShamDEVICE

Sham stimulation

Sham

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Veterans between the ages of 18 and 75 will be included with a diagnosis of PTSD based on DSM-5 criteria

You may not qualify if:

  • Subjects will be excluded with:
  • a history of mild traumatic brain injury (mTBI) based on VA Criteria
  • moderate or greater TBI
  • positive pregnancy test
  • meningitis or other neurological disorder
  • alcohol or substance abuse use disorder based on DSM-5 criteria within the past 12 months
  • current or lifetime history of schizophrenia, schizoaffective disorder, bipolar I disorder, anorexia nervosa or bulimia, based on DSM-5
  • active suicidal ideation with a plan
  • a history of serious medical or neurological illness, such as cardiovascular, gastrointestinal, hepatic, renal, neurologic or other systemic illness that would preclude participation based on clinical judgment of the PI
  • active opiate or benzodiazepine treatment
  • history of structural abnormality on brain MRI or CT if one has been performed in the past

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atlanta VA Medical and Rehab Center, Decatur, GA

Decatur, Georgia, 30033-4004, United States

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Doug J Bremner, MD

    Atlanta VA Medical and Rehab Center, Decatur, GA

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Doug J Bremner, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Sham stimulation comparison
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: tcVNS versus sham stimulation
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 15, 2022

First Posted

August 26, 2022

Study Start

October 1, 2022

Primary Completion (Estimated)

July 8, 2027

Study Completion (Estimated)

November 10, 2027

Last Updated

March 3, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

De identified data will be made available three months after study completion

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Three months after study completion
Access Criteria
Three months after study completion for twelve months

Locations